Chen Fei, Castranova Vince
The Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.
Cancer Res. 2007 Dec 1;67(23):11093-8. doi: 10.1158/0008-5472.CAN-07-1576.
The notion that nuclear factor-kappaB (NF-kappaB) is a tumor-promoting transcription factor has become a widely accepted dogma in biology. However, recent findings suggest an inhibitory role for NF-kappaB in carcinogenesis and tumorigenesis. Although the tumor suppressor-like effect of NF-kappaB remains to be rigorously established by further studies using cellular and animal models, these latest findings warrant caution with respect to blockage of NF-kappaB activation as a broad strategy in treating cancers.
核因子-κB(NF-κB)是一种促进肿瘤的转录因子,这一观点已成为生物学中广泛接受的教条。然而,最近的研究结果表明NF-κB在致癌作用和肿瘤发生中具有抑制作用。尽管通过细胞和动物模型的进一步研究,NF-κB类似肿瘤抑制因子的作用仍有待严格证实,但这些最新发现警示在将阻断NF-κB激活作为治疗癌症的广泛策略时应谨慎行事。